97 related articles for article (PubMed ID: 3056425)
21. Induction of colony-stimulating factor and stimulation of stem cell proliferation by injection of muroctasin.
Yamaguchi F; Akasaki M; Tsukada W
Arzneimittelforschung; 1988 Jul; 38(7A):980-3. PubMed ID: 3263869
[TBL] [Abstract][Full Text] [Related]
22. [The immunostimulating activity of muramyl dipeptide and its derivatives].
Karsonova MI; Andronova TM; Pinegin BV; Khaitov RM
Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):104-10. PubMed ID: 10852007
[No Abstract] [Full Text] [Related]
23. N-[trans-2-[[2'-(acetylamino)cyclohexyl]oxy]acetyl]-L-alanyl-D-glutamic acid: a novel immunologically active carbocyclic muramyl dipeptide analogue.
Kikelj D; Pecar S; Kotnik V; Stalc A; Wraber-Herzog B; Simcic S; Ihan A; Klamfer L; Povsic L; Grahek R; Suhadolc E; Hocevar M; Hönig H; Rogi-Kohlenprath R
J Med Chem; 1998 Feb; 41(4):530-9. PubMed ID: 9484503
[TBL] [Abstract][Full Text] [Related]
24. [Muramyl dipeptide derivatives in experimental and clinical use].
Kaliuzhin OV
Zh Mikrobiol Epidemiol Immunobiol; 1998; (1):104-8. PubMed ID: 9532704
[No Abstract] [Full Text] [Related]
25. [Mechanism of action and clinical effectiveness of immunomodulator glucosaminylmuramyl dipeptide (licopide)].
Ivanov VT; Andronova TM; Nesmeianov VA; Pinegin BV; Ledger P; Bomford R; Khaitov RM
Klin Med (Mosk); 1997; 75(3):11-5. PubMed ID: 9229604
[No Abstract] [Full Text] [Related]
26. [Use of muramyl dipeptides in models of synthetic vaccines].
Audibert F
Boll Ist Sieroter Milan; 1985; 64(2):95-102. PubMed ID: 3896261
[TBL] [Abstract][Full Text] [Related]
27. Stimulation of resistance of immunocompromised mice by a muramyl dipeptide analog.
Osada Y; Mitsuyama M; Matsumoto K; Une T; Otani T; Ogawa H; Nomoto K
Infect Immun; 1982 Sep; 37(3):1285-8. PubMed ID: 6752024
[TBL] [Abstract][Full Text] [Related]
28. [Synthesis of N-acetyl-muramyl-dipeptide--an immunoadjuvant].
Chen ZY; Chen LF; Gong XQ
Yao Xue Xue Bao; 1982 Jun; 17(6):425-30. PubMed ID: 7148465
[No Abstract] [Full Text] [Related]
29. Synthesis of immunologically active muramyl dipeptide derivatives containing a quinonyl moiety via aminoacyl intermediates.
Fukuda T; Kobayashi S; Yukimasa H; Imada I; Fujino M; Azuma I; Yamamura Y
Chem Pharm Bull (Tokyo); 1981 Aug; 29(8):2215-21. PubMed ID: 7318034
[No Abstract] [Full Text] [Related]
30. Restorative activity of muroctasin on leukopenia associated with anticancer treatment.
Tsubura E; Nomura T; Niitani H; Osamura S; Okawa T; Tanaka M; Ota K; Nishikawa H; Masaoka T; Fukuoka M
Arzneimittelforschung; 1988 Jul; 38(7A):1070-4. PubMed ID: 3190800
[TBL] [Abstract][Full Text] [Related]
31. Synthetic muramyl peptides: their origin, present status, and future prospects. Introductory remarks.
Chedid L
Fed Proc; 1986 Oct; 45(11):2531-3. PubMed ID: 3758370
[No Abstract] [Full Text] [Related]
32. Stimulation of plasma fibronectin production in mice by muroctasin.
Endo N; Okuda T; Osada Y; Zen-Yoji H
Arzneimittelforschung; 1988 Jul; 38(7A):997-8. PubMed ID: 3190806
[TBL] [Abstract][Full Text] [Related]
33. Stimulation of non-specific resistance to infection by muroctasin.
Otani T; Une T; Osada Y
Arzneimittelforschung; 1988 Jul; 38(7A):969-76. PubMed ID: 3056426
[TBL] [Abstract][Full Text] [Related]
34. Induction of a CD8+ cytotoxic T lymphocyte response to soluble antigen given together with a novel muramyl dipeptide adjuvant, N-acetyl-D-glucosaminyl-(beta 1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine (GMDP).
Hornung RL; Longo DL; Gowda VL; Kwak LW
Ther Immunol; 1995 Feb; 2(1):7-14. PubMed ID: 7553072
[TBL] [Abstract][Full Text] [Related]
35. [Muramyl dipeptide (MDP): its origin, mechanism of action and prospects for its use].
Castrillón LE
Salud Publica Mex; 1987; 29(6):492-9. PubMed ID: 3125614
[No Abstract] [Full Text] [Related]
36. Physico-chemical properties of muroctasin.
Moroi R; Yamazaki K; Hirota T; Watanabe S; Kataoka K; Ichinose M
Arzneimittelforschung; 1988 Jul; 38(7A):953-9. PubMed ID: 3190802
[TBL] [Abstract][Full Text] [Related]
37. Romurtide, a synthetic muramyl dipeptide derivative, accelerates peripheral platelet recovery in nonhuman primate chemotherapy model.
Namba K; Nitanai H; Otani T; Azuma I
Vaccine; 1996 Oct; 14(14):1322-6. PubMed ID: 9004440
[TBL] [Abstract][Full Text] [Related]
38. Recent advances concerning the use of muramyl dipeptide derivatives as vaccine potentiators.
Audibert F; Chedid L
Prog Clin Biol Res; 1980; 47():325-38. PubMed ID: 7010376
[No Abstract] [Full Text] [Related]
39. The activation of human monocytes by liposome-encapsulated muramyl dipeptide analogues.
Lopez-Berestein G; Mehta K; Mehta R; Juliano RL; Hersh EM
J Immunol; 1983 Apr; 130(4):1500-2. PubMed ID: 6300230
[No Abstract] [Full Text] [Related]
40. Anti-stress activity in a muramyl-dipeptide.
Singh N; Jain RK; Gupta CM; Anand N
Indian J Exp Biol; 1990 Jul; 28(7):686-7. PubMed ID: 2272655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
